Loading...
Optimising the use of mTOR inhibitors in renal transplantation
Renal transplantation is the treatment of choice for end-stage renal failure. Although advances in immunosuppression have led to improvements in short-term outcomes, graft survival beyond 5 to 10 years has not improved. One of the major causes of late renal allograft failure is chronic allograft nep...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3834524/ https://ncbi.nlm.nih.gov/pubmed/24565283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-1440-2-S1-S4 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|